Recurrent Nasopharyngeal Undifferentiated Carcinoma
3 clinical trials · Condition
◉ Watch Recurrent Nasopharyngeal Undifferentiated Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer (NCT04458909) | National Cancer Institute (NCI) | 2020-12-09 |
| Cyclophosphamide for Nasopharyngeal Carcinoma (NCT02794077) | The University of Hong Kong | 2008-01-01 |
| Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma (NCT00336063) | National Cancer Institute (NCI) | 2006-03-03 |
Track Recurrent Nasopharyngeal Undifferentiated Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.